Analysis of the “GSE4922” dataset (n = 248 breast cancer patients) [36] for RFS showed that high geminin expressers (n = 124) had significantly shorter RFS than low expressers (n = 124, HR = 1.33, 95% CI = 1.05–1.69, p = 0.0165, Figure 3L). Here, GMNN is linked to breast cancer.